Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis.
about
Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection--Liver: The "Musketeer" in the SpotlightMitochondrial Molecular Pathophysiology of Nonalcoholic Fatty Liver Disease: A Proteomics ApproachRelationship between Non-Alcoholic Fatty Liver Disease and Psoriasis: A Novel Hepato-Dermal Axis?Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIVNAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk.Environmental/lifestyle factors in the pathogenesis and prevention of type 2 diabetes.Waist Gain Is Associated with a Higher Incidence of Nonalcoholic Fatty Liver Disease in Korean Adults: A Cohort StudyBidirectional association between nonalcoholic fatty liver disease and type 2 diabetes in Chinese population: Evidence from the Dongfeng-Tongji cohort study.Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin Resistance.Alcohol and Steatosis: The Japanese ParadoxEthnicity matters: A Systematic Review and Meta-Analysis of the Non-Linear Relationship Between Alcohol Consumption and Prevalence and Incidence of Hepatic SteatosisAssociations between sitting time and non-alcoholic fatty liver diseases in Chinese male workers: a cross-sectional study.Association between liver enzymes and incident type 2 diabetes in Singapore Chinese men and womenmiR33a/miR33b* and miR122 as Possible Contributors to Hepatic Lipid Metabolism in Obese Women with Nonalcoholic Fatty Liver Disease.Association of low-density lipoprotein cholesterol within the normal range and NAFLD in the non-obese Chinese population: a cross-sectional and longitudinal study.Regulatory landscape of AGE-RAGE-oxidative stress axis and its modulation by PPARγ activation in high fructose diet-induced metabolic syndrome.Association between liver function and metabolic syndrome in Chinese men and women.Health and economic benefits of reducing sugar intake in the USA, including effects via non-alcoholic fatty liver disease: a microsimulation model.The pharmacological management of NAFLD in children and adolescents.The association of non-alcoholic fatty liver disease with lung function: A survey design analysis using propensity score.The Role of Nuclear Receptors in the Pathophysiology, Natural Course, and Drug Treatment of NAFLD in Humans.Nonalcoholic fatty liver disease: cause or consequence of type 2 diabetes?Pharmacological interventions for non-alcohol related fatty liver disease (NAFLD): an attempted network meta-analysis.Gamma-glutamyltransferase-friend or foe within?Hyperuricaemia and risk of nonalcoholic fatty liver disease: A meta-analysis.Pharmacological management of nonalcoholic fatty liver disease in type 2 diabetes.Prevalence of abnormal serum liver enzymes in patients with type 2 diabetes mellitus: a cross-sectional study from China.Prevalence of elevated alanine transaminase in Australia and its relationship to metabolic risk factors: A cross-sectional study of 9,447 people.Association between physical activity and risk of nonalcoholic fatty liver disease: a meta-analysis.Lipid accumulation product is a powerful tool to predict non-alcoholic fatty liver disease in Chinese adults.Effects of Dapagliflozin on Body Composition and Liver Tests in Patients with Nonalcoholic Steatohepatitis Associated with Type 2 Diabetes Mellitus: A Prospective, Open-label, Uncontrolled Study.Schisandra polysaccharide inhibits hepatic lipid accumulation by downregulating expression of SREBPs in NAFLD mice.Nonalcoholic fatty liver was associated with asymptomatic gallstones in a Chinese population.NAFLD: Is There Anything New under the Sun?Serum alanine aminotransferase/aspartate aminotransferase ratio is one of the best markers of insulin resistance in the Chinese population.Nonalcoholic fatty liver disease: Evolving paradigms.Treatment options for alcoholic and non-alcoholic fatty liver disease: A review.NAFLD, Hepatotropic Viruses, and Cardiometabolic Risk.Global epidemiology of nonalcoholic fatty liver disease: Meta-analytic assessment of prevalence, incidence, and outcomes.Associations between fatty liver index and asymptomatic intracranial vertebrobasilar stenosis in Chinese population.
P2860
Q26752583-2362CB21-51E0-45B9-97A2-740FE3943C18Q26753043-AFFDF8AD-1C65-4F47-86D3-6BFDE1AE64B5Q26767276-E242FCB3-9B52-4849-A20D-066409F46956Q28079826-F50A44E3-E738-4A99-BAAB-5F0AF2D91AB2Q33844463-ADC9245B-30C0-47ED-B299-E0F927D16F41Q33916655-74291867-E2EB-4D17-BC4A-C009A3BAB082Q36078507-FA30EB0E-09D3-47C9-BD78-B3DF24F67F64Q36325487-00BB02F0-880A-43F1-8DB2-C767686AAB3CQ36953626-5EDDD143-00E3-464B-928B-DFA63B3E42C3Q37034826-FD205F46-A90F-43BE-B45B-70DA8A3F6F10Q37035153-2AD01668-5771-41CB-9697-4B94C590A96CQ37251885-D3ABD727-5E5F-4609-A0FC-138D30D85F82Q37271471-F650F8C1-D2A0-4EDE-BE68-7A01A55EE867Q37377220-73B45376-712E-4C36-89FF-33C9B66ED46DQ37517243-E6D35776-35C9-44F6-B6C3-84D312C817A9Q37586657-380CC8C2-CBC9-477B-A9C9-E8F1F3A8E26DQ37710720-128304DD-2129-4CE4-9C1E-3588726701F9Q38642356-F7099349-BDCB-4B37-A368-2EA8C79048B4Q38643266-4DFD7663-0936-45ED-9E0E-CE4D2372F4E4Q38658136-7EED823E-1670-4F9B-94F4-4396756B4285Q38752520-F7D39FDD-34F9-4E1C-AF32-523B3458C1C8Q38859044-AF4431A9-2884-4E40-BB55-759A83FABA88Q38867031-6ADFA756-18F6-4A70-8669-C1C63F6CC981Q38924608-3E112972-592C-43CB-A5CB-479594B0EA80Q39021862-A16D309E-8656-4166-8688-6C86249ED336Q39170225-11C4AF23-6380-44A0-B2B8-C1D42E2E7881Q39343214-726D968B-E728-46B0-9D16-30780A7585E6Q39795518-DE113649-49A1-4B7E-8D15-67C164BF1E15Q41078413-6CD0D2AE-6206-4DE0-A520-7F0F7E5BC17AQ41209147-A72DB2E6-FAD6-4110-830B-9E2EE4FA35C9Q41623607-ACAF762B-CB1F-461E-A5EB-389E45BEA656Q42074184-41DEC130-7568-4370-BE91-A27A8476B8DAQ42365416-27B8EBAE-9749-466C-8158-73FF008F9177Q42365749-91CC19DD-E26E-4AB4-A6F0-31A939E06B6FQ42373541-EC2B7926-D8E6-4711-BFA0-72874A8928F0Q42695154-F205A4E2-7899-43AF-989F-734F59529785Q42695159-15EC185B-7B1B-4ACC-800F-C6B95A61AEAEQ43546902-F41D0FF0-1428-4197-B705-AC3006B7D33AQ44087514-5D2F5DB5-EB54-4B26-8201-CB07AFE2DFFAQ47127406-5E5E1ED2-B158-4EF5-A7C2-9C99684235CB
P2860
Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Nonalcoholic fatty liver disea ...... atic review and meta-analysis.
@en
type
label
Nonalcoholic fatty liver disea ...... atic review and meta-analysis.
@en
prefLabel
Nonalcoholic fatty liver disea ...... atic review and meta-analysis.
@en
P2093
P50
P356
P1476
Nonalcoholic fatty liver disea ...... matic review and meta-analysis
@en
P2093
Alberto Roverato
Dante Romagnoli
Enrica Baldelli
Giovanni Targher
Stefano Zona
P304
P356
10.1111/JGH.13264
P577
2016-05-01T00:00:00Z